Pre-order Enquiry
Request Free Sample
Global Preimplantation Genetic Testing Market Growth (Status and Outlook) 2022-2028
SKU ID : LPI-20420084 | Publishing Date : 08-Mar-2022 | No. of pages : 114
Request Sample
Request Customization
Check Discounts
As the global economy mends, the 2021 growth of Preimplantation Genetic Testing will have significant change from previous year. According to our researcher latest study, the global Preimplantation Genetic Testing market size is USD million in 2022 from USD 338.6 million in 2021, with a change of % between 2021 and 2022. The global Preimplantation Genetic Testing market size will reach USD 509.6 million in 2028, growing at a CAGR of 6.0% over the analysis period.
The United States Preimplantation Genetic Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Preimplantation Genetic Testing market, reaching US$ million by the year 2028. As for the Europe Preimplantation Genetic Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Preimplantation Genetic Testing players cover Illumina, Thermo Fisher, Agilent Technologies, and Perkinelmer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Illumina
Thermo Fisher
Agilent Technologies
Perkinelmer
Coopersurgical
Abbott Laboratories
Natera
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute
Good Start Genetics
Invicta Genetics
Combimatrix
Genea Limited
Progenesis
The United States Preimplantation Genetic Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Preimplantation Genetic Testing market, reaching US$ million by the year 2028. As for the Europe Preimplantation Genetic Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Preimplantation Genetic Testing players cover Illumina, Thermo Fisher, Agilent Technologies, and Perkinelmer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Illumina
Thermo Fisher
Agilent Technologies
Perkinelmer
Coopersurgical
Abbott Laboratories
Natera
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute
Good Start Genetics
Invicta Genetics
Combimatrix
Genea Limited
Progenesis
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
